Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation-Reference-Cited by-同舟云学术

Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation

Published:2015-08-25 Issue:12 Volume:55 Page:2983-3000
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kleinman Steve¹,Stassinopoulos Adonis²

Affiliation:

1. University of British ColumbiaVictoria British Columbia Canada

2. Global Scientific AffairsCerus CorporationConcord California

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.13259

Reference146 articles.

1. A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States

2. WhitakerB HinkinsS.The 2011 national blood collection and utilization survey report [Internet]. Washington (DC); US Department of Health and Human Services; 2013 [cited 2014 Dec]. Available from:http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf

3. Trends in red blood cell transfusion and 30-day mortality among hospitalized patients

4. Modeling the risk of an emerging pathogen entering the Canadian blood supply

5. The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypovolemic Shock;Critical Care Obstetrics;2024-04

2. Pathogen reduced red blood cells as an alternative to irradiated and washed components with potential for up to 42 days storage;BLOOD TRANSFUS-ITALY;2024

3. New ultraviolet C light‐based method for pathogen inactivation of red blood cell units;Transfusion;2022-09-10

4. Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction;Transfusion;2022-06-21

5. Thalassaemia;The Lancet;2022-06